IP will develop a comprehensive clinical compendium overview across the five major clinical compendia organizations recognized for coverage determination within oncology/hematology, for the management of competitive products within a specific disease state in order to inform your company’s clinical compendium strategy.

The overview will aim to identify if competitive products are being managed within a specific disease area, across clinical compendia. Where the disease is being managed, the overview will contain an in-depth review of each clinical compendium reference organization, including but not limited to the competitive market basket, required levels of evidence, submission process, clinical, economic, and other submission criteria in scope for each submission.